Cancer biomarkers span a broad biological spectrum, including proteins, metabolites, and nucleic acids detectable in samples such as tissue biopsies and blood. 1 At the beginning of a biomarker ...
Critically, the study validated the bridging strategy using OncoHost's PROphet (R) platform--an AI-powered, plasma proteomics-based model designed to predict immunotherapy outcomes in patients with ...
Plasma brain-derived tau is emerging as a sensitive biomarker for Alzheimer’s disease and acute neurological disorders, ...
Comparative Analysis of Generative Pre-Trained Transformer Models in Oncogene-Driven Non–Small Cell Lung Cancer: Introducing the Generative Artificial Intelligence Performance Score This ...
In a recent editorial published in Current Pharmaceutical Analysis (Volume 18, Issue 6, 2022), researchers Dr. Behrouz Seyfinejad and Dr. Abolghasem Jouyban highlight the importance of method ...
Faculty in the Medical Devices and Diagnostics Hub develop statistical methods for the design, evaluation, and validation of diagnostic tools and medical devices. Their work includes biomarker ...
However, regardless of which trial is conducted, the overfitting of data might be a substantial issue, meaning that the number of parameters in a model is too great relative to the number of samples, ...
Researchers at The University of Texas MD Anderson Cancer Center have developed a new computational approach designed to ...
Background: The Prognostic Lung Fibrosis Consortium (PROLIFIC) was formed to develop well-qualified assays suitable for use as prognostic biomarkers within the context of clinical trials for Idiopathic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results